Treatment of immuno-resistant disease

Details Treatment of immuno-resistant disease Treatment of immuno-resistant disease

A - Human Necessities

61

K

167/103.1

A61K 37/66 (1990.01)

Patent

CA 1320905

ABSTRACT OF THE DISCLOSURE Neoplastic disease, hyperallergenicity, autoimmune disorders characterized by chronic tissue degenerative inflammation and immuno-resistant viral infections are treated by the administration of iterferon at a dosage of about 0.1 to about 5 IU/lb per day by contacting said interferon with oral/pharyngeal mucosa. Interferon is administered in solution or in a novel solid unitary dosage form adapted to be dissolved in saliva when placed in the mouth.

550816

Affiliated with

Also associated with

Rating

Treatment of immuno-resistant disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of immuno-resistant disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of immuno-resistant disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1313113